LEADER 02492nam 2200613 a 450 001 9910823976503321 005 20200520144314.0 010 $a0-309-17876-2 010 $a1-281-72684-2 010 $a9786611726843 010 $a0-309-12199-X 035 $a(CKB)1000000000704702 035 $a(EBL)3378370 035 $a(SSID)ssj0000179352 035 $a(PQKBManifestationID)11177409 035 $a(PQKBTitleCode)TC0000179352 035 $a(PQKBWorkID)10126346 035 $a(PQKB)10297477 035 $a(MiAaPQ)EBC3378370 035 $a(Au-PeEL)EBL3378370 035 $a(CaPaEBR)ebr10235165 035 $a(CaONFJC)MIL172684 035 $a(OCoLC)923278968 035 $a(EXLCZ)991000000000704702 100 $a20081103d2008 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aInitial guidance for an update of the National Vaccine Plan $ea letter report to the National Vaccine Program Office /$fCommittee on the Review of Priorities in the National Vaccine Plan, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies 205 $a1st ed. 210 $aWashington, D.C. $cNational Academies Press$d2008 215 $a1 online resource (39 p.) 300 $aDescription based upon print version of record. 311 $a0-309-12198-1 320 $aIncludes bibliographical references. 327 $a""Title""; ""Reviewers""; ""Contents""; ""Background""; ""Changes Since 1994""; ""Progress Since 1994""; ""Guidance for Developing a New National Vaccine Plan""; ""Concluding Remarks""; ""Appendix A References""; ""Appendix B Statement of Task""; ""Appendix C Meeting One Agenda""; ""Appendix D 1994 National Vaccine Plan Goals, Objectives, and Anticipated Outcomes"" 517 3 $aLetter report to the National Vaccine Program Office 606 $aVaccination$zUnited States 606 $aImmunization$zUnited States 606 $aCommunicable diseases$zUnited States$xPrevention 615 0$aVaccination 615 0$aImmunization 615 0$aCommunicable diseases$xPrevention. 676 $a614.4 712 02$aInstitute of Medicine (U.S.).$bBoard on Population Health and Public Health Practice. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910823976503321 996 $aInitial guidance for an update of the National Vaccine Plan$94093761 997 $aUNINA